Yoshimura Food Holdings K.K. Logo

Yoshimura Food Holdings K.K.

Acquires and revitalizes Japanese food SMEs via a support platform for global expansion.

2884 | T

Overview

Corporate Details

ISIN(s):
JP3958400008
LEI:
Country:
Japan
Address:
千代田区内幸町二丁目2番2号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Yoshimura Food Holdings K.K. is a holding company dedicated to preserving and growing Japan's food culture. Its core business is the merger and acquisition (M&A) of food-related small and medium-sized enterprises (SMEs) that possess high-quality products and unique manufacturing techniques but face business succession or growth challenges. The company operates a unique "SME support platform," providing comprehensive management assistance to its group companies in areas such as sales, marketing, and product development. This model focuses on long-term value creation and synergy, aiming to revitalize acquired businesses and expand the reach of their diverse food products to both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-15 09:06
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-10-15 09:05
Interim Report
半期報告書-第18期(2025/03/01-2026/02/28)
Japanese 207.9 KB
2025-06-02 07:08
Post-Annual General Meeting Information
臨時報告書
Japanese 21.4 KB
2025-05-30 07:25
Registration Form
確認書
Japanese 8.1 KB
2025-05-30 07:24
Governance Information
内部統制報告書-第17期(2024/03/01-2025/02/28)
Japanese 22.1 KB
2025-05-30 07:23
Annual Report
有価証券報告書-第17期(2024/03/01-2025/02/28)
Japanese 1.2 MB
2025-04-15 08:08
Management Discussion and Analysis
臨時報告書
Japanese 18.9 KB
2025-04-08 09:53
Capital/Financing Update
臨時報告書
Japanese 19.5 KB
2025-02-28 08:07
Capital/Financing Update
臨時報告書
Japanese 19.3 KB
2025-01-10 06:53
Regulatory News Service
臨時報告書
Japanese 18.5 KB
2024-12-09 08:34
Legal Proceedings Report
臨時報告書
Japanese 18.6 KB
2024-10-15 09:46
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-10-15 09:45
Interim Report
半期報告書-第17期(2024/03/01-2025/02/28)
Japanese 199.7 KB
2024-07-12 08:42
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-07-12 08:41
Quarterly Report
四半期報告書-第17期第1四半期(2024/03/01-2024/05/31)
Japanese 158.7 KB

Automate Your Workflow. Get a real-time feed of all Yoshimura Food Holdings K.K. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Yoshimura Food Holdings K.K.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Yoshimura Food Holdings K.K. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.